Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells (Q39679931)

13 September 2017

title

Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells (English)

1 reference

13 September 2017

Xiuling Chi

1

1 reference

13 September 2017

Hsin-Hsiung Tai

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

Experimental Cell Research

13 September 2017

published in

1 reference

13 September 2017

volume

316

1 reference

13 September 2017

issue

14

1 reference

13 September 2017

page(s)

2251-2259

1 reference

Cyclooxygenases: structural, cellular, and molecular biology

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Prostaglandin catabolizing enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Indomethacin, a cox inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

The IL-4 receptor: signaling mechanisms and biologic functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Interleukins and STAT signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Reduction of tumor necrosis factor ? and interleukin-1? levels in human synovial tissue by interleukin-4 and glucocorticoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Enzymic synthesis of (15S)-[15-3H]prostaglandins and their use in the development of a simple and sensitive assay for 15-hydroxyprostaglandin dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Stimulation of prostaglandin E2 synthesis by interleukin-1beta is amplified by interferons but inhibited by interleukin-4 in human amnion-derived WISH cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Role of p38 MAPK on the down-regulation of matrix metalloproteinase-9 expression in rat astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF-beta 1-stimulated primary human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

PMA-induced up-regulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

IL-4 regulation of p38 MAPK signalling is dependent on cell type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

p38 Mitogen-activated protein kinase regulates interleukin-4-induced gene expression by stimulating STAT6-mediated transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.06.001

10.1016/J.YEXCR.2010.06.001

7 January 2021

Identifiers

DOI

1 reference

release_ogwhxytrmrco3oiniekixzko4m

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ogwhxytrmrco3oiniekixzko4m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference